Page 33 - Read Online
P. 33

restore facial volume and contours, but complications such   Asia, the Middle East, and Latin America) and awaiting FDA
         as granulomas and paraffinomas years after treatment have   approval.
         restricted their use for aesthetic treatment.
                                                             After injection, the implant is encapsulated and surrounded
         Silicone                                            by fibroblasts and microphages, theoretically preventing
         No silicone product for soft tissue augmentation has been   migration.  Many studies have supported  the usage of
         approved by FDA. The major indication for FDA-approved   Aquamid for the treatment of various rhytides, facial
         products is retinal detachment with removal of the material   contouring, and correction of HIV lipoatrophy. PAAG has
         after reattachment. In soft tissue augmentation,  removal   been evaluated in clinical trials for facial contouring,
         of silicone is not performed. The use of liquid silicon is off   deep rhytides  and folds, [90-92]   and  the  correction of facial
         label.  For decades, horrendous complications have been   lipoatrophy [93,94]  with efficacy similar to nonanimal stabilized
             [80]
         reported from silicone injections into breasts, and its use has   hyaluronic acid and duration of at least 1 year when used for
         been banned by many authorities. Adverse effects have also   the treatment of nasolabial folds. [95-98]
         been noted after use for facial tissue augmentation. [81-83]  After
         illegal  silicone  injection,  the  silicone  embolism  syndrome   For the past decade, Aquamid has gained popularity  as
         has been observed with potential fatal outcome in 24% of   injectable  filler. Similar  to other facial fillers, there have
         patients.  Symptoms  and signs  of  the  “silicone  syndrome”   been reported cases of inflammation, nodule and granuloma
         include dyspnea, fever, cough, hemoptysis, chest pain,   formation, and delayed hypersensitivity reactions. Histologic
                                                        [84]
         hypoxia, alveolar hemorrhage, and altered consciousness.    analysis  of Aquamid  injected  into  the  subcutaneous layer
         They have almost been abandoned nowadays.           revealed bioactive product that underwent cell infiltration
                                                             and integration into tissues between weeks 1 and 8.  In
                                                                                                          [99]
         PMMA                                                some  instances, surgical extraction of the polyacrylamide
         PMMA is rigid, transparent and colorless, thermoplastic   product was necessary to correct the adverse event of
         permanent skin filler with low cost, easy accessibility, and   nodule formation. Careful attention to injection technique
         potential to achieve lasting results. PMMA has been used   and sterile precautions are necessary to minimize
         as an injectable filler to treat hollows and reduce rhytids.   unwanted reactions. In addition, there have been recent
         PMMA injections have been associated with several side   recommendations for the usage of prophylactic antibiotics
         effects; especially they may lead to some undesirable effects   to  minimize  complications  from  bacterial  injections  and
         in the eyelids and periocular region.               biofilm formation when injecting Aquamid. [100,101]

         First-generation  polymerized  PMMA  microspheres  are   Polyvinylpyrrolidone-silicone suspension
         purified with diameter  greater than 20  μm,  which may   This  is  a permanent  filler comprised of particles of
         produced foreign body granulomas; Lemperle et al. [85,86]    polymerized silicone elastomer, 100-600  μm in size,
         postulate that  larger  PMMA  microspheres  (30 to 50  μm)   dispersed in a carrier of polyvinylpyrrolidone (Bioplastique;
                                                        [87]
         may  resist  phagocytosis.  However,  Bachmann  et al.    Uroplasty BV, Geleen, The Netherlands). The suspension has
         demonstrated that a giant cell reaction still occurs with larger   been mostly used for lip augmentation and the correction
         PMMA microspheres. Complications of PMMA injection were   of facial rhytids. It should be injected in the subcutaneous
         classified as nodular masses,  inflammation,  allergies  and   tissue. They usually remain at the injected site and could
         skin hypopigmentation. The most affected sides were the   avoid from being phagocytosed by macrophagesdue to the
         lips (46%), followed by periocular, nasolabial folds, forehead,   large size of the silicone particles. They would produce a
         and cheeks. PMMA injection to the periocular region may   local foreign body reaction and fibrosis, which contributes
         be lead to erythema, hardening of the local tissues, edema,   to the filling effect. [102]  Local side effects include induration,
         and formation of nodules and eyelid malposition, which are   swelling, and granuloma formation. [103-105]
         associated with  fibrotic  nodules,  giant  cell inflammation.
         The best treatment for these PMMA injection complications   Histopathologically, granulomas secondary to this filler
         remains uncertain. Corticosteroid injection may have limited   consist of irregularly shaped cystic spaces containing
         efficacy while surgical debulking may achieve favorable   translucent, jagged “popcorn” nonbirefringent particles of
         results.                                            varying size dispersed in a sclerotic stroma surrounded by
               [88]
                                                             abundant multinucleated foreign body giant cells. [102-105]
         Aquamid (polyacrylamide hydrogel)
         Aquamid has been used extensively  for soft tissue   Polyalkylimide gel
                                                 [89]
         augmentation and body contouring for 2 decades.  Aquamid   Polyalkylimide  gel  is  a  permanent  hydrophilic translucent
         is a biocompatible and nonabsorbable hydrogel consisting   gel  filler composed of a hydrophilic biopolymer  with
         of 97.5% water and 2.5% cross-linked polyacrylamide (PAAG).   96% sterile  water  and 45% polyalkylimide  polymer (Bio-
         The  gel  is  manufactured  through  polymerization  of  the   Alcamid;  Polymekon, Brindisi, Italy), and different from
         acrylamide monomers and N, N’-methylenbisacrylamide.    polyacrylamide. It has been used to increase volume in
                                                        [89]
         Aquamid is currently approved in several countries in   the  cheeks in  HIV  patients  with  facial lipoatrophy related
         Europe, European Conformity marked in Europe in 2001   to antiretroviral therapy and for gluteal augmentation,
         for facial augmentation and minor body contouring, PAAG   correction of irregularities  after liposculpture, scar
         is available in more than 40 countries worldwide (Europe,   depressions, and posttraumatic subcutaneous atrophy and
         96                                                                         Plast Aesthet Res || Vol 3 || Mar 23, 2016
   28   29   30   31   32   33   34   35   36   37   38